Siemens Healthineers receives Frost & Sullivan Award for Precision Imaging
Recognition for a Visionary Approach in Diagnostic Imaging and Leading Contribution to Precision Medicine


Siemens Healthineers’ Precision Imaging recognized with Global Visionary Innovation Leadership Award 2019

Siemens Healthineers received this Award for our leading efforts in establishing imaging as an active contributor to precision medicine. We are proud to be recognized as thought leaders in precision medicine and to see that our efforts to provide high-value care and to improve patient outcomes are advancing healthcare. This underlines the impact forward-thinking ideas and solutions have on the far-reaching changes currently taking place throughout the healthcare system. Our goal: the right treatment at the right time for every patient.

Dr. Christoph Zindel, President Diagnostic Imaging, Siemens Healthineers
“This demonstrates not only our technological and innovation leadership in imaging but also confirms that our work is making a real difference on the front lines of healthcare. As Frost & Sullivan point out, precision medicine is one of the foremost transformative forces redefining our approach to care delivery – a view we strongly share.” Dr. Christoph Zindel, President Diagnostic Imaging, Siemens Healthineers
Dr. Ghada Trotabas, Head of Marketing and Sales Operations, Siemens Healthineers
“We are happy to be honored with the Frost & Sullivan Award for Visionary Innovation Leadership. One of our core objectives is to enable healthcare providers on their journey to expanding precision medicine. This award shows that our efforts are being recognized and achieving results. Congratulations to everyone who contributed to it!” Dr. Ghada Trotabas, Head of Marketing and Sales Operations, Siemens Healthineers

Siemens Healthineers is said to be pushing boundaries in precision medicine with its visionary developments and solutions:

  • Boasting PET-CT quantification capabilities, which enable accuracy when imaging a tumor to determine its size, location, and volume
  • Developing BioMatrix technology on its magnetic resonance imaging (MRI) platforms, featuring respiratory and kinetic sensors
  • Enabling personalized medicine with real-time ultrasound imaging and innovative applications adapted to individual patient
  • Integrating data and supporting decisions along the clinical pathway, with artificial intelligence built into its AI-Pathway Companion

Frost & Sullivan also emphasize that Siemens Healthineers is taking a holistic view of its wide portfolio, pulling all capabilities together to enable this effort from diagnosis to therapy. The personnel in charge of leading this effort have a cross-portfolio view of how all the verticals can contribute to this paradigm.

About the Award

Frost & Sullivan presents this award to companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development.